Breaking News Instant updates and real-time market news.

PRTA

Prothena

$56.23

2.03 (3.75%)

07:13
05/19/17
05/19
07:13
05/19/17
07:13

Prothena initiated with a Buy at BTIG

BTIG analyst Robert Hazlett initiated Prothena with a Buy and an $80 price target due to the material potential for its programs in amyloidosis, Parkinson's, and inflammatory diseases.

  • 06

    Jun

PRTA Prothena
$56.23

2.03 (3.75%)

04/12/17
PIPR
04/12/17
INITIATION
Target $69
PIPR
Overweight
Prothena initiated with an Overweight at Piper Jaffray
Piper Jaffray analyst Steven Breazzano started Prothena with an Overweight rating and $69 price target. The analyst has a favorable view of the company's lead drug, NEOD001 for AL amyloidosis
04/12/17
CANT
04/12/17
INITIATION
Target $86
CANT
Overweight
Prothena initiated with an Overweight at Cantor
Cantor analyst William Tanner initiated Prothena with an Overweight and an $86 price target saying he views the company's intrinsic proteinmisfolding and cell-trafficking knowledge as integral to an R&D engine that could yield novel therapies to treat important diseases. Not only does Prothena have Orphan drug candidates NEOD1 and PRX004 for treating amyloidopathies, but Tanner believes the Parkinson's disease and psoriatic arthritis programs has the potential to deliver greater value.
05/16/17
RHCO
05/16/17
NO CHANGE
RHCO
Prothena has positive read through from Ionis safety issues, says SunTrust
SunTrust analyst Yun Zhong says that safety issues with Ionis' inotersen during a Phase III trial are positive for Prothena. The analyst says that Prothena's new drug, PRX004, could have a better safety profile than its previous drug, NEOD001,. He notes that PRX004 has a different mechanism of action than Ionis' drug, and he thinks the discrepancy could enable Prthena's drug to have a better safety profile. He keeps a Buy rating on Prothena.
05/16/17
PIPR
05/16/17
NO CHANGE
Target $69
PIPR
Overweight
Piper Jaffray sees positive readthrough for Prothena from Ionis data
Piper Jaffray analyst Steven Breazzano argues that investors should "take a closer look" at Prothena (PRTA) and its PRX004 product following the recent amyloid neuropathy data from Ionis Pharmaceuticals (IONS). Prothena's candidate is expected to enter the clinic in early 2018, and Breazzano argues that there is "room for differentiation" in the space, as the drug clears the protein buildup that characterizes amyloidosis rather than directly shutting off production, as with Ionis and Alnylam's (ALNY) approaches. "At a minimum," the analyst says, a deposit-clearing approach would be complementary to production-stopping drugs. Breazzano reiterates an Overweight rating on Prothena.

TODAY'S FREE FLY STORIES

PINC

Premier

$34.21

0.04 (0.12%)

20:14
10/23/17
10/23
20:14
10/23/17
20:14
Downgrade
Premier rating change  »

Premier downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VBTX

Veritex

$26.94

-0.17 (-0.63%)

19:29
10/23/17
10/23
19:29
10/23/17
19:29
Earnings
Veritex reports Q3 core EPS 28c, consensus 30c »

For the three months…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

OIBR

Oi S.A.

19:08
10/23/17
10/23
19:08
10/23/17
19:08
Hot Stocks
Oi: Court postpones general meeting of creditors »

Oi announced that, at the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HAS

Hasbro

$89.75

-8.44 (-8.60%)

18:24
10/23/17
10/23
18:24
10/23/17
18:24
Hot Stocks
Hasbro CEO: Had a very strong quarter »

Expects to make a revised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

LGF.A

Lionsgate

$29.59

-0.5 (-1.66%)

, LGF.B

Lionsgate

$28.44

-0.6 (-2.07%)

18:07
10/23/17
10/23
18:07
10/23/17
18:07
Hot Stocks
Lionsgate names Rohit Jain to head new office in Mumbai, India »

Lionsgate (LGF.A, LGF.B)…

LGF.A

Lionsgate

$29.59

-0.5 (-1.66%)

LGF.B

Lionsgate

$28.44

-0.6 (-2.07%)

DISH

Dish

$48.98

-0.32 (-0.65%)

VDTH

Videocon d2h

$8.00

-0.22 (-2.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Nov

  • 09

    Nov

ALE

Allete

$78.62

-0.31 (-0.39%)

18:06
10/23/17
10/23
18:06
10/23/17
18:06
Hot Stocks
Wisconsin jury delivers verdict in favor of U.S. Water in Novozymes suit »

U.S. Water, an Allete…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

  • 05

    Nov

SYT

Syngenta

$92.12

0.05 (0.05%)

, ADAM

A.D.A.M.

18:04
10/23/17
10/23
18:04
10/23/17
18:04
Hot Stocks
Syngenta and Adama to sell portfolio of crop products to Nufarm for $490M »

Syngenta (SYT) announced…

SYT

Syngenta

$92.12

0.05 (0.05%)

ADAM

A.D.A.M.

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIS

Disney

$98.70

-0.7 (-0.70%)

17:54
10/23/17
10/23
17:54
10/23/17
17:54
Periodicals
Disney sees new 'Thor' movie outpacing earlier ones, Bloomberg says »

Disney sees "Thor:…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Nov

VIVO

Meridian Bioscience

$15.20

-0.6 (-3.80%)

17:31
10/23/17
10/23
17:31
10/23/17
17:31
Hot Stocks
Meridian Bioscience comments on FDA Warning Letter issued to subsidiary »

Meridian Bioscience…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APRN

Blue Apron

$5.15

0.07 (1.38%)

17:30
10/23/17
10/23
17:30
10/23/17
17:30
Hot Stocks
Blue Apron names Lainie Cooney chief HR officer »

Blue Apron announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

WSFS

WSFS Financial

$50.25

-0.5 (-0.99%)

17:29
10/23/17
10/23
17:29
10/23/17
17:29
Hot Stocks
WSFS Financial raises quarterly dividend 29% to 9c per share »

The dividend will be paid…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 06

    Nov

  • 15

    Nov

CONN

Conn's

$26.85

-0.75 (-2.72%)

17:28
10/23/17
10/23
17:28
10/23/17
17:28
Hot Stocks
Conn's sees Q3 SSS down 9% to down 5%, provision for bad debts at $56M-$61M »

The company states:…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WSFS

WSFS Financial

$50.25

-0.5 (-0.99%)

17:27
10/23/17
10/23
17:27
10/23/17
17:27
Earnings
WSFS Financial reports Q3 EPS 64c, consensus 65c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 06

    Nov

  • 15

    Nov

VBTX

Veritex

$26.94

-0.17 (-0.63%)

17:27
10/23/17
10/23
17:27
10/23/17
17:27
Hot Stocks
Veritex names Michael Bryan chief information officer »

Veritex Holdings, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

TNDM

TNDM

17:25
10/23/17
10/23
17:25
10/23/17
17:25
Hot Stocks
Breaking Hot Stocks news story on TNDM »

Armistice Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

CLB

Core Laboratories

$87.75

-1.74 (-1.94%)

17:21
10/23/17
10/23
17:21
10/23/17
17:21
Hot Stocks
Core Laboratories sees Q4 free cash flow exceeding net income »

Fourth quarter 2017 FCF…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

CLB

Core Laboratories

$87.75

-1.74 (-1.94%)

17:20
10/23/17
10/23
17:20
10/23/17
17:20
Earnings
Core Laboratories sees Q4 revenue approximately 58c, consensus 58c »

Sees Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

CLB

Core Laboratories

$87.75

-1.74 (-1.94%)

17:18
10/23/17
10/23
17:18
10/23/17
17:18
Earnings
Core Laboratories reports Q3 GAAP EPS 48c, consensus 44c »

Reports Q3 revenue $166M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

LKQ

LKQ Corp.

$37.06

-0.28 (-0.75%)

, DOV

Dover

$95.54

0.59 (0.62%)

17:17
10/23/17
10/23
17:17
10/23/17
17:17
Hot Stocks
LKQ Corp to acquire aftermarket business of Dover subsidiary Warn Industries »

LKQ Corporation (LKQ)…

LKQ

LKQ Corp.

$37.06

-0.28 (-0.75%)

DOV

Dover

$95.54

0.59 (0.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

KNL

Knoll

$20.00

-0.02 (-0.10%)

, HMST

HomeStreet

$28.60

-0.25 (-0.87%)

17:17
10/23/17
10/23
17:17
10/23/17
17:17
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS: Knoll…

KNL

Knoll

$20.00

-0.02 (-0.10%)

HMST

HomeStreet

$28.60

-0.25 (-0.87%)

CR

Crane

$83.61

-0.5 (-0.59%)

IPXL

Impax

$20.35

-0.9 (-4.24%)

ICPT

Intercept

$65.60

-1.25 (-1.87%)

SWK

Stanley Black & Decker

$158.19

-1.93 (-1.21%)

NKE

Nike

$53.66

0.6 (1.13%)

HNI

HNI Corporation

$42.29

-0.57 (-1.33%)

WHR

Whirlpool

$182.50

0.04 (0.02%)

ZION

Zions Bancorp

$46.39

-0.37 (-0.79%)

JBT

John Bean Technologies

$104.05

0.1 (0.10%)

IMDZ

Immune Design

CRBP

Corbus Pharmaceuticals

$7.40

-0.375 (-4.82%)

QURE

uniQure

$18.52

-0.75 (-3.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 06

    Nov

  • 08

    Nov

  • 09

    Nov

  • 09

    Nov

  • 13

    Nov

  • 14

    Nov

  • 14

    Nov

  • 15

    Nov

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

HBI

Hanesbrands

$22.86

-0.63 (-2.68%)

17:17
10/23/17
10/23
17:17
10/23/17
17:17
Initiation
Hanesbrands initiated at Deutsche Bank »

Hanesbrands initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

PVH

PVH Corp.

$129.68

1.37 (1.07%)

17:15
10/23/17
10/23
17:15
10/23/17
17:15
Initiation
PVH Corp. initiated at Deutsche Bank »

PVH Corp. initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NYT

New York Times

$19.55

0.1 (0.51%)

17:15
10/23/17
10/23
17:15
10/23/17
17:15
Hot Stocks
Breaking Hot Stocks news story on New York Times »

Darsana Capital Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USEG

U.S. Energy

$1.01

0.01 (1.00%)

17:07
10/23/17
10/23
17:07
10/23/17
17:07
Hot Stocks
U.S. Energy announces participation in upcoming drilling program »

U.S. Energy announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KOS

Kosmos

$7.44

-0.07 (-0.93%)

, HES

Hess Corp.

$45.21

0.18 (0.40%)

17:05
10/23/17
10/23
17:05
10/23/17
17:05
Hot Stocks
Kosmos to acquire interest in exploration licenses in Gulf of Guinea for $650M »

Kosmos Energy announced…

KOS

Kosmos

$7.44

-0.07 (-0.93%)

HES

Hess Corp.

$45.21

0.18 (0.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

  • 06

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.